[The use of vasopressin during portal bypass (author's transl)].
Vasopressin was infused intra-arterially or intravenously during 12 portal bypass operations. In comparison with a control group (without vasopressin), there was a very significant reduction in blood loss and portal pressure, and a moderate increase in arterial blood pressure.
D001794:Blood Pressure / Q000187:drug effects; D005260:Female; D006488:Hemostasis, Surgical / Q000379:methods; D006801:Humans; D006975:Hypertension, Portal / Q000601:surgery; D007261:Infusions, Intra-Arterial; D007263:Infusions, Parenteral; D008297:Male; D008875:Middle Aged; D011167:Portacaval Shunt, Surgical / Q000379:methods* / Q000401:mortality; D011169:Portal Vein; D014661:Vasoconstriction; D014667:Vasopressins / Q000008:administration & dosage / Q000627:therapeutic use*
D014667:Vasopressins
Utilisation de la vasopressine au cours des dérivations portales.